Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,946 | -46,289 | -32,401 | -20,841 | -9,702 |
| Depreciation Amortization | 171 | 795 | 561 | 328 | 145 |
| Accounts payable and accrued liabilities | 1,712 | 975 | 409 | 630 | -329 |
| Other Working Capital | -1,217 | 5,639 | 4,068 | 2,568 | -422 |
| Other Operating Activity | -529 | 4,771 | 3,769 | 2,065 | 1,638 |
| Operating Cash Flow | $-12,809 | $-34,109 | $-23,594 | $-15,250 | $-8,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -147 | -1,166 | -1,015 | -485 | -97 |
| Purchase Of Investment | -49,764 | 7,165 | 6,165 | 3,865 | 2,450 |
| Investing Cash Flow | $-49,911 | $5,999 | $5,150 | $3,380 | $2,353 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 51 | 48,903 | 35,275 | 9,936 | 2,165 |
| Financing Cash Flow | $51 | $48,903 | $35,275 | $9,936 | $2,165 |
| Beginning Cash Position | 122,222 | 101,429 | 101,429 | 101,429 | 101,429 |
| End Cash Position | 59,553 | 122,222 | 118,260 | 99,495 | 97,277 |
| Net Cash Flow | $-62,669 | $20,793 | $16,831 | $-1,934 | $-4,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,809 | -34,109 | -23,594 | -15,250 | -8,670 |
| Capital Expenditure | -147 | -1,166 | -1,015 | -485 | -97 |
| Free Cash Flow | -12,956 | -35,275 | -24,609 | -15,735 | -8,767 |